The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Regulatory News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 22.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 4.00 (18.182%)
Open: 24.00
High: 0.00
Low: 0.00
Prev. Close: 24.00
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Mar 2024 11:18

RNS Number : 3482I
Oncimmune Holdings PLC
26 March 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYQ94H38

Issuer Name

ONCIMMUNE HOLDINGS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

22-Mar-2024

6. Date on which Issuer notified

25-Mar-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.485800

3.528400

6.014200

4459057

Position of previous notification (if applicable)

2.485800

3.427200

5.913000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYQ94H38

1843032

2.485800

Sub Total 8.A

1843032

2.485800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

2616025

3.528400

Sub Total 8.B1

2616025

3.528400%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

25-Mar-2024

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLJFMBTMTBTBRI
Date   Source Headline
25th Sep 20187:00 amRNSGrant of options
24th Sep 20187:00 amRNSBoard Change
13th Sep 20187:00 amRNSAppointment of Marco Casarin as General Manager
26th Jul 201812:33 pmRNSNotification & Public Disclosure of a Transaction
4th Jun 20187:38 amRNSBusiness Update
24th May 20187:00 amRNSNew Distribution Agreements for EarlyCDT®-Lung Kit
23rd May 20187:00 amRNSOncimmune Publishes Study in PLOS ONE
14th May 20187:00 amRNSOncimmune Launches EarlyCDT®-Liver Test in the US
23rd Apr 20187:00 amRNSPDMR Notification
11th Apr 20182:01 pmRNSHolding(s) in Company
27th Mar 20188:00 amRNSFinal tranche of £10m equity investment
27th Mar 20187:00 amRNSAppointment of Dr Adam Hill as CMO and CSO
13th Feb 20187:00 amRNSInterim Results for the half year ended 30 Nov 17
5th Feb 20187:01 amRNSUniversity of Nottingham share sale
5th Feb 20187:00 amRNSHoldings in Company
2nd Feb 20184:45 pmRNSTotal Voting Rights
29th Jan 20187:00 amRNSFirst tranche of £10m equity investment
23rd Jan 20187:00 amRNSBusiness Update and Notice of Interim Results
22nd Jan 201811:21 amRNSResult of General Meeting
9th Jan 20187:00 amRNSAppointment of Non-Executive Director
4th Jan 20187:30 amRNSNotice of General Meeting
2nd Jan 20187:00 amRNSFramework agreement, licence and £10m investment
21st Dec 20177:00 amRNSValidation of EarlyCDT®-Liver test
30th Nov 20173:53 pmRNSHolding(s) in Company
29th Nov 20179:55 amRNSResult of AGM
27th Nov 20177:00 amRNSAppointment of joint brokers
24th Nov 20177:00 amRNSSatisfaction of Delayed Completion Placing
22nd Nov 20177:00 amRNSDeadline extended for Delayed Completion Placing
16th Nov 20177:00 amRNSDistribution agreement signed for Iran
9th Nov 20177:00 amRNSLaunch of "Finger Stick" Sample Collection
3rd Nov 20177:00 amRNSAnnual Report and Accounts and AGM Notification
27th Oct 201710:32 amRNSDirector/PDMR Shareholding
20th Oct 20177:00 amRNSResults for the year ended 31 May 2017
18th Oct 20177:00 amRNSDistribution Agreement in Poland
10th Oct 201711:15 amRNSHoldings in Company
10th Oct 20177:00 amRNSNotice of Results
27th Sep 20172:11 pmRNSSuccessful £5.0m placing
26th Sep 20175:12 pmRNSProposed placing to raise up to £5.3m
19th Sep 20177:00 amRNSEarlyCDT®-Lung Kit Distribution Agreements
18th Sep 20177:00 amRNSData presented at the 11th Annual ILCA
14th Sep 20177:00 amRNSBusiness Update
29th Aug 20177:00 amRNSOncimmune and Scancell Present Data
20th Jul 20171:59 pmRNSExercise of Options & 2007 Share Option Scheme
7th Jul 20177:00 amRNSHolding(s) in Company
5th Jun 20177:00 amRNSBusiness Update and New Distribution Agreements
31st May 20177:00 amRNSCE Mark for EarlyCDT-Lung Kit
17th May 20177:00 amRNSGRANT OF OPTIONS
28th Apr 20177:00 amRNSFirst Distribution Agreements Signed
24th Apr 20179:18 amRNSGRANT OF OPTIONS
3rd Apr 20177:00 amRNSAppointment of Senior VP, MA & Reimbursement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.